What one share of Biofrontera holds
Biofrontera’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.93 |
|---|---|
| Profit | −$0.54 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.67 |
| Cash and investments | $0.33 |
| Book value | $0.42 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | $54.72 | −$85.63 | — | — | — | $13.26 |
| 2022 | $27.13 | −$0.61 | $0.04 | −$15.36 | — | $17.89 |
| 2023 | $22.03 | −$13.02 | $0.00 | −$16.10 | — | $3.16 |
| 2024 | $6.77 | −$3.22 | $0.00 | −$1.86 | — | $0.50 |
| 2025 | $4.10 | −$1.04 | $0.00 | −$1.31 | — | $0.90 |
Common questions about Biofrontera
How much does one share of Biofrontera earn?
Over the last 12 months, Biofrontera lost $0.54 for each share on $3.93 of sales.
Does Biofrontera pay a dividend?
Biofrontera didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Biofrontera’s book value per share?
Biofrontera’s book value is $0.42 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Biofrontera have?
Each share of Biofrontera has $0.33 of cash and investments, as of June 30, 2026.
What is Biofrontera’s free cash flow per share?
−$0.67 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Biofrontera bought back shares?
Biofrontera’s share count rose about 2210% from 2021 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.